IL20 and breast cancer: The most frequent gains found in our BRCAX tumors (Table 3) have been previously observed to be amplified in breast cancer [7, 8, 12], and contain at least four genes of interest PDE4DIP/Myomegalin [32, 33], IL19, IL20 [34–36] and FAIM3 [37–39].